Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (101-110 of 297) with videos related to

Pageof 30
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 7, 2019
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.
Cancers|September 9, 2023
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung MetastasesKonstantinos Grapatsas, Fabian Dörr, Hruy Menghesha, et al.
Scientific Reports|October 17, 2018
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular levelMohamad K Hammoud, Hesham K Yosef, Tatjana Lechtonen, et al.
Digital Health|January 8, 2024
Drivers and barriers of patients' acceptance of video consultation in cancer careAngelina Nurtsch, Martin Teufel, Lisa Maria Jahre, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2016
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain MetastasesMartin Schuler, Yi-Long Wu, Vera Hirsh, et al.
Cancers|June 10, 2023
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological InpatientsEva Warnecke, Maria Rosa Salvador Comino, Dilara Kocol, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2023
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapyLuca Hegedüs, Özlem Okumus, Fabian Mairinger, et al.
Thoracic Cancer|June 16, 2022
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Oncotarget|May 12, 2016
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinibJohanna Falkenhorst, Susanne Grunewald, Thomas Mühlenberg, et al.
Pageof 30

Showing results (101-110 of 297) with videos related to

Sort By:
Pageof 30
Lung Cancer (Amsterdam, Netherlands)|December 7, 2019
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.
Cancers|September 9, 2023
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung MetastasesKonstantinos Grapatsas, Fabian Dörr, Hruy Menghesha, et al.
Scientific Reports|October 17, 2018
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular levelMohamad K Hammoud, Hesham K Yosef, Tatjana Lechtonen, et al.
Digital Health|January 8, 2024
Drivers and barriers of patients' acceptance of video consultation in cancer careAngelina Nurtsch, Martin Teufel, Lisa Maria Jahre, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2016
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain MetastasesMartin Schuler, Yi-Long Wu, Vera Hirsh, et al.
Cancers|June 10, 2023
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological InpatientsEva Warnecke, Maria Rosa Salvador Comino, Dilara Kocol, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2023
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapyLuca Hegedüs, Özlem Okumus, Fabian Mairinger, et al.
Thoracic Cancer|June 16, 2022
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Oncotarget|May 12, 2016
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinibJohanna Falkenhorst, Susanne Grunewald, Thomas Mühlenberg, et al.
Pageof 30